Gastroenterology
Volume 134, Issue 1 , Pages 131-144 , January 2008

γ-Secretase Inhibitors Enhance Taxane-Induced Mitotic Arrest and Apoptosis in Colon Cancer Cells

  • Takashi Akiyoshi

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Masafumi Nakamura

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Kosuke Yanai

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Shuntaro Nagai

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Junji Wada

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Kenichiro Koga

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Hiroshi Nakashima

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Norihiro Sato

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Masao Tanaka

      Affiliations

    • Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Mitsuo Katano

      Affiliations

    • Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • Corresponding Author InformationAddress requests for reprints to: Mitsuo Katano, MD, Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. fax: (81) 92-642-6221.

Received 4 January 2007 ,Accepted 27 September 2007.

References 

  1. Van Cutsem E, Costa F. Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?. JAMA. 2005;294:2758–2760
  2. Wolfe MS. Therapeutic strategies for Alzheimer’s disease. Nat Rev Drug Discov. 2002;1:859–866
  3. Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science. 2006;314:777–781
  4. McCarthy JV. Involvement of presenilins in cell-survival signalling pathways. Biochem Soc Trans. 2005;33:568–572
  5. Fre S, Huyghe M, Mourikis P, et al. Notch signals control the fate of immature progenitor cells in the intestine. Nature. 2005;435:964–968
  6. van Es JH, van Gijn ME, Riccio O, et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963
  7. De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999;398:518–522
  8. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194:237–255
  9. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22:6598–6608
  10. Zagouras P, Stifani S, Blaumueller CM, et al. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A. 1995;92:6414–6418
  11. Patel NS, Li JL, Generali D, et al. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005;65:8690–8697
  12. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res. 2006;66:1517–1525
  13. Rieder CL, Maiato H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell. 2004;7:637–651
  14. O’Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A. 2000;97:13103–13107
  15. Castedo M, Perfettini JL, Roumier T, et al. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 2002;9:1287–1293
  16. Balint K, Xiao M, Pinnix CC, et al. Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression. J Clin Invest. 2005;115:3166–3176
  17. Qin JZ, Stennett L, Bacon P, et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Mol Cancer Ther. 2004;3:895–902
  18. Curry CL, Reed LL, Golde TE, et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi’s sarcoma tumor cells. Oncogene. 2005;24:6333–6344
  19. Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology. 2005;128:1354–1368
  20. Pazdur R, Lassere Y, Soh LT, et al. Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma. Ann Oncol. 1994;5:468–470
  21. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253–265
  22. O’Connor DS, Wall NR, Porter AC, et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell. 2002;2:43–54
  23. Tan M, Jing T, Lan KH, et al. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Mol Cell. 2002;9:993–1004
  24. Cai D, Latham VM, Zhang X, et al. Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells. Cancer Res. 2006;66:9270–9280
  25. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11:725–730
  26. Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23:1155–1165
  27. Fernandez-Majada V, Aguilera C, et al. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A. 2007;104:276–281
  28. Kato H, Sakai T, Tamura K, et al. Functional conservation of mouse Notch receptor family members. FEBS Lett. 1996;395:221–224
  29. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678–689
  30. Martinez Arias A, Zecchini V, Brennan K. CSL-independent Notch signalling: a checkpoint in cell fate decisions during development?. Curr Opin Genet Dev. 2002;12:524–533
  31. Swanton C, Marani M, Pardo O, et al. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell. 2007;11:498–512
  32. Swanton C, Tomlinson I, Downward J. Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle. 2006;5:818–823
  33. Green RA, Kaplan KB. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol. 2003;163:949–961
  34. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol. 2001;3:433–438
  35. Hadjihannas MV, Bruckner M, Jerchow B, et al. Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci U S A. 2006;103:10747–10752
  36. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997;386:623–627
  37. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 1998;392:300–303
  38. Tighe A, Johnson VL, Albertella M, et al. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2001;2:609–614
  39. Milano J, McKay J, Dagenais C, et al. Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci. 2004;82:341–358

 The authors report that no conflicts of interest exist.

 Supported by General Scientific Research Grants (17591414, 18390350, 18659372, and 18591468) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The Notch2 monoclonal antibody developed by Spyros Artavanis-Tsakonas was obtained from the University of Iowa Developmental Hybridoma Studies bank.

PII: S0016-5085(07)01807-0

doi: 10.1053/j.gastro.2007.10.008

Gastroenterology
Volume 134, Issue 1 , Pages 131-144 , January 2008

Article Tools

* Image Usage & Resolution